{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:52:42Z","timestamp":1793638362612,"version":"4.5.1"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Pregnant patients are often on immunosuppressant medications, most commonly to manage transplantation or autoimmune disorders. Most immunosuppressant agents, including tacrolimus, corticosteroids, azathioprine, and calcineurin inhibitors, are safe during pregnancy and lactation. However, mycophenolic acid is associated with higher risks of birth defects and should be avoided in pregnancy. Tacrolimus, the commonly used drug in transplantation medicine and autoimmune disorders, requires monitoring of serum levels for dose adjustment, particularly during pregnancy. Although no pregnancy-specific therapeutic range exists, the general target range is 5\u201315 ng\/mL, and pregnant patients may require higher doses to achieve therapeutic levels. Adherence to prescribed immunosuppressive regimens is crucial to prevent graft rejection and autoimmune disorder flare-ups. This review aims to provide essential information about the use of immunosuppressant medications in pregnant individuals. With a rising number of pregnant patients undergoing organ transplantations or having autoimmune disorders, it is important to understand the implications of the use of these medications during pregnancy.<\/jats:p>","DOI":"10.1097\/aog.0000000000005512","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T22:00:40Z","timestamp":1705442440000},"page":"e94-e106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Immunosuppressant Medications in Pregnancy"],"prefix":"10.1097","volume":"143","author":[{"given":"Antonio F.","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis D.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bpobgyn.2014.07.020","article-title":"Immunosuppressive drugs and fetal outcome","volume":"28","author":"Coscia","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/ajt.12238","article-title":"Mycophenolate fetal toxicity and risk evaluation and mitigation strategies","volume":"13","author":"Kim","year":"2013","journal-title":"Am J Transpl"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/09612033221148334","article-title":"Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective single-center analysis in Japan","volume":"32","author":"Kitada","year":"2023","journal-title":"Lupus"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): molecular and cellular mechanisms","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther Drug Monit"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/FTD.0b013e3182708edf","article-title":"Pharmacokinetics of tacrolimus during pregnancy","volume":"34","author":"Zheng","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ogc.2022.10.012","article-title":"Principles of obstetric pharmacology: maternal physiologic and hepatic metabolism changes","volume":"50","author":"Stika","year":"2023","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R10-20250423","first-page":"3105","article-title":"Adverse effects associated with the use of FK 506","volume":"23","author":"Fung","year":"1991","journal-title":"Transpl Proc"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DMSO.S19027","article-title":"New onset diabetes after transplantation (NODAT): an overview","volume":"4","author":"Pham","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection: European FK506 Multicentre Liver Study Group","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/00007890-199204000-00040","article-title":"QT prolongation and torsades de pointes after administration of FK506","volume":"53","author":"Johnson","year":"1992","journal-title":"Transplantation"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-199808150-00021","article-title":"Sinus arrest during tacrolimus treatment: was the QT interval prolonged?","volume":"66","author":"Calandra","year":"1998","journal-title":"Transplantation"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00007890-199808270-00021","article-title":"QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report","volume":"66","author":"Hodak","year":"1998","journal-title":"Transplantation"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1715163516641136","article-title":"Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management","volume":"149","author":"Tisdale","year":"2016","journal-title":"Can Pharm J (Ott)"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0970-1591.39547","article-title":"Opportunistic infections (non-cytomegalovirus) in live related renal transplant recipients","volume":"25","author":"Vinod","year":"2009","journal-title":"Indian J Urol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trre.2008.05.001","article-title":"Pregnancy after transplantation","volume":"22","author":"Armenti","year":"2008","journal-title":"Transpl Rev (Orlando)"},{"key":"R19-20250423","first-page":"65","article-title":"Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation","author":"Coscia","year":"2010","journal-title":"Clin Transpl"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3109\/14767058.2011.634461","article-title":"Pregnancy outcomes after kidney transplantation: immunosuppressive therapy comparison","volume":"25","author":"Perales-Puchalt","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1111\/bcp.15414","article-title":"Pregnancy and neonatal outcomes in women receiving calcineurin inhibitors: a systematic review and meta-analysis","volume":"88","author":"Akiyama","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R22-20250423","first-page":"905","article-title":"Safety of tacrolimus in pregnancy","volume":"60","author":"Nevers","year":"2014","journal-title":"Can Fam Physician"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2005.00969.x","article-title":"Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation","volume":"5","author":"McKay","year":"2005","journal-title":"Am J Transpl"},{"issue":"suppl 4","key":"R24-20250423","first-page":"50","article-title":"European best practice guidelines for renal transplantation, section IV: long-term management of the transplant recipient: IV.10: pregnancy in renal transplant recipients","volume":"17","year":"2002","journal-title":"Nephrol Dial Transpl"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12882-019-1560-2","article-title":"Clinical practice guideline on pregnancy and renal disease","volume":"20","author":"Wiles","year":"2019","journal-title":"BMC Nephrol"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology"},{"issue":"suppl 3","key":"R28-20250423","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transpl"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2012.04140.x","article-title":"Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis","volume":"12","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2012","journal-title":"Am J Transpl"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.ajog.2023.04.022","article-title":"Society for Maternal-Fetal Medicine Consult Series# 66: prepregnancy evaluation and pregnancy management of patients with solid organ transplants","volume":"229","author":"Irani","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5500\/wjt.v12.i8.211","article-title":"Hypertension in kidney transplant recipients","volume":"12","author":"Alexandrou","year":"2022","journal-title":"World J Transpl"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/AOG.0b013e318187d00c","article-title":"Pregnancy after solid organ transplantation","volume":"112","author":"Mastrobattista","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1203\/00006450-197305000-00004","article-title":"The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term","volume":"7","author":"Beitins","year":"1973","journal-title":"Pediatr Res"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R40-20250423","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R41-20250423","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid\u2010induced clinical adverse events: frequency, risk factors and patient's opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"R42-20250423","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.etap.2017.02.021","article-title":"Recent advances in the study of 11\u03b2-Hydroxysteroid dehydrogenase type 2 (11\u03b2-HSD2) Inhibitors","volume":"52","author":"Zhou","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"key":"R43-20250423","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9378(78)90768-8","article-title":"The transfer and metabolism of corticosteroids in the perfused human placenta","volume":"132","author":"Levitz","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"R44-20250423","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/tera.1420510107","article-title":"Teratogenic potential of corticosteroids in humans","volume":"51","author":"Fraser","year":"1995","journal-title":"Teratology"},{"key":"R45-20250423","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta\u2010analysis of epidemiological studies","volume":"62","author":"Park\u2010Wyllie","year":"2000","journal-title":"Teratology"},{"key":"R46-20250423","first-page":"1083","article-title":"Using corticosteroids during pregnancy: are topical, inhaled, or systemic agents associated with risk?","volume":"50","author":"Oren","year":"2004","journal-title":"Can Fam Physician"},{"key":"R47-20250423","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"key":"R49-20250423","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ajt.14085","article-title":"Mycophenolate and pregnancy: teratology principles and National Transplantation Pregnancy Registry experience","volume":"17","author":"Moritz","year":"2017","journal-title":"Am J Transplant"},{"key":"R50-20250423","doi-asserted-by":"crossref","first-page":"e923536","DOI":"10.12659\/AOT.923536","article-title":"Sirolimus adverse event profile in a non-clinical trial cohort of heart transplantation patients","volume":"26","author":"Sallam","year":"2021","journal-title":"Ann Transplant"},{"key":"R52-20250423","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/TP.0b013e3182154267","article-title":"Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation","volume":"91","author":"Framarino dei Malatesta","year":"2011","journal-title":"Transplantation"},{"key":"R53-20250423","doi-asserted-by":"crossref","first-page":"52","DOI":"10.12659\/AOT.883694","article-title":"Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation","volume":"17","author":"Keller","year":"2012","journal-title":"Ann Transplant"},{"key":"R54-20250423","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ijo.2021.5234","article-title":"Everolimus therapy and side-effects: a systematic review and meta-analysis","volume":"59","author":"Arena","year":"2021","journal-title":"Int J Oncol"},{"key":"R56-20250423","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1111\/j.1432-2277.2011.01356.x","article-title":"Pregnancy under everolimus\u2010based immunosuppression","volume":"24","author":"Veroux","year":"2011","journal-title":"Transpl Int"},{"key":"R57-20250423","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2012.05.012","article-title":"Pregnancy in a kidney transplant patient treated with everolimus","volume":"60","author":"Carta","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R58-20250423","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1111\/ctr.12044","article-title":"The role of belatacept in transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agents","volume":"27","author":"Heemann","year":"2013","journal-title":"Clin Transplant"},{"key":"R59-20250423","first-page":"385","article-title":"Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update","volume":"6","author":"Wojciechowski","year":"2012","journal-title":"Biologics"},{"key":"R60-20250423","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-6143.2011.03976.x","article-title":"Summary of the US FDA approval of belatacept","volume":"12","author":"Archdeacon","year":"2012","journal-title":"Am J Transplant"},{"key":"R61-20250423","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40261-013-0153-2","article-title":"Pharmacokinetics, pharmacodynamics, and immunogenicity of belatacept in adult kidney transplant recipients","volume":"34","author":"Shen","year":"2014","journal-title":"Clin Drug Invest"},{"key":"R62-20250423","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0976-500X.92499","article-title":"Belatacept: a worthy alternative to cyclosporine?","volume":"3","author":"Melvin","year":"2012","journal-title":"J Pharmacol Pharmacother"},{"key":"R63-20250423","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1097\/TP.0000000000004634","article-title":"Outcomes with belatacept exposure during pregnancy in kidney transplant recipients: a case series","volume":"107","author":"Coscia","year":"2023","journal-title":"Transplantation"},{"key":"R64-20250423","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"R65-20250423","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35101056","article-title":"Pharmacogenetics and cancer therapy","volume":"1","author":"Relling","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"R66-20250423","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-200208000-00003","article-title":"Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism","volume":"12","author":"Schwab","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R67-20250423","first-page":"117","article-title":"Immunosuppressives in pregnant transplant patients\u2014what risks?","volume":"30","author":"Yeast","year":"1987","journal-title":"Pharmacology"},{"key":"R70-20250423","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0272-6386(12)81116-4","article-title":"Dialysis, transplantation, and pregnancy","volume":"17","author":"Davison","year":"1991","journal-title":"Am J kidney Dis"},{"key":"R71-20250423","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00007890-197901000-00007","article-title":"Pregnancy in renal transplant patients a review","volume":"27","author":"Rudolph","year":"1979","journal-title":"Transplantation"},{"key":"R72-20250423","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00007890-199402270-00004","article-title":"National Transplantation Pregnancy Registry\u2014outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients","volume":"57","author":"Armenti","year":"1994","journal-title":"Transplantation"},{"key":"R73-20250423","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/bdra.20583","article-title":"Early pregnancy azathioprine use and pregnancy outcomes","volume":"85","author":"Cleary","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R74-20250423","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrgastro.2013.135","article-title":"IBD medications during pregnancy and lactation","volume":"11","author":"Nielsen","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R75-20250423","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","article-title":"Breast-feeding after transplantation","volume":"28","author":"Constantinescu","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R76-20250423","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/AOG.0000000000000978","article-title":"Care of the pregnant patient with inflammatory bowel disease","volume":"126","author":"Mahadevan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R77-20250423","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"R78-20250423","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R79-20250423","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R80-20250423","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1097\/MIB.0000000000000923","article-title":"Experts opinion on the practical use of azathioprine and 6-mercaptopurine in inflammatory bowel disease","volume":"22","author":"Mottet","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R81-20250423","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5500\/wjt.v6.i1.144","article-title":"Overview of extended release tacrolimus in solid organ transplantation","volume":"6","author":"Patel","year":"2016","journal-title":"World J Transpl"},{"key":"R82-20250423","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jcph.1082","article-title":"Evaluation of flexible tacrolimus drug concentration monitoring approach in patients receiving extended-release once-daily tacrolimus tablets","volume":"58","author":"Philosophe","year":"2018","journal-title":"J Clin Pharmacol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:01:32Z","timestamp":1745427692000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005512","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"2023-10-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}